Last reviewed · How we verify

NCT04333212

HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine Cervix

Completed NA Last updated 3 April 2020
What this trial tests

NA trial testing DR. Chip HPV genotyping IVD kit in Cervical Intraepithelial Neoplasia in 1,103 participants. Completed in 8 July 2014.

Timeline
12 December 2012
Primary endpoint
30 December 2013
8 July 2014

Quick facts

Lead sponsorChang Gung Memorial Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment1,103
Start date12 December 2012
Primary completion30 December 2013
Estimated completion8 July 2014
Sites4 locations across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 21 to 65, female only, with Cervical Intraepithelial Neoplasia or Human Papillomavirus Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

High-risk type human papillomavirus (HPV) is the known etiological agent of cervical cancer. HPV testing and risk stratification by genotyping has been recognized as an effective cervical screening program. A chip for HPV DNA typing based on type-specific polymerase chain reaction (PCR), DR. HPV Genotyping IVD Kit (HPV-27) was developed for genotyping of 27 common HPV types including all high-risk types. We studied its agreement, sensitivity, and specificity compared to DNA sequencing as the gold standard.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cervical Intraepithelial Neoplasia

Currently open trials in the same condition.

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04333212.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing